BioLife Solutions, Inc. (BLFS)
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
$35.25-0.79%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
QuarterlyIQ Insights · BLFS
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 106.7 | 96.2 | 82.3 | 68.0 | 76.2 | 119.2 | 48.1 | 27.4 | 19.7 | 11.0 | 8.2 | 6.4 | 6.2 | 8.9 | 5.7 | 2.8 |
| Total Revenues | — | — | — | — | — | — | — | — | — | — | — | — | 6.2 | 8.9 | 5.7 | 2.8 |
| Cost of Revenues | — | 34.1 | — | 26.7 | — | — | — | 8.8 | 6.2 | 4.3 | 3.4 | 2.6 | 3.2 | 5.2 | 3.4 | 1.4 |
| Gross Profit | — | 62.1 | — | 41.3 | — | — | — | — | 13.5 | 6.7 | 4.8 | 3.8 | 3.0 | 3.8 | 2.3 | 1.4 |
| Operating Expenses & Income | ||||||||||||||||
| R&D Expenses | 9.8 | 7.6 | 7.9 | 5.5 | 8.7 | 11.8 | 6.7 | 3.2 | 1.3 | 1.2 | 2.0 | 1.4 | 0.9 | 0.5 | 0.5 | 0.5 |
| Operating Income | 1.7 | (16.6) | (7.1) | (17.2) | (5.9) | (35.2) | (6.2) | (0.2) | 3.7 | (1.1) | (4.9) | (5.0) | (3.1) | (0.3) | (0.9) | (1.2) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | — | — | — | — | — | — | 0.0 | 0.0 | 0.2 | — | 0.0 | 0.2 | 0.7 | 0.7 | 0.7 |
| Interest & Investment Income | — | — | — | — | — | — | 0.1 | 0.5 | — | — | — | — | — | — | — | 0.0 |
| Net Interest Expenses | — | — | — | — | — | — | — | (0.5) | — | — | — | — | — | — | — | 0.7 |
| Other Non-Operating Income / Expenses | 5.1 | 4.5 | (4.3) | 5.0 | 1.1 | 6.1 | 5.0 | (3.0) | (28.7) | (1.5) | (3.2) | 0.0 | (0.2) | (0.8) | (0.7) | (0.7) |
| Asset Writedown | — | — | — | 15.5 | 110.4 | 0.0 | 0.0 | — | — | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | 6.8 | (12.1) | (11.4) | (12.2) | (4.8) | (27.8) | (0.6) | (3.2) | 2.3 | — | — | — | — | — | — | — |
| Income Tax Expense | (42.4) | 0.0 | (0.0) | (0.1) | (5.2) | (20.1) | (3.3) | (1.5) | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — |
| Net Income | ||||||||||||||||
| Minority Interest | — | — | — | — | — | — | — | — | — | 0.0 | (1.2) | (0.8) | (0.1) | — | — | — |
| Net Income | 58.0 | (4.6) | (20.2) | (68.0) | (139.8) | (8.9) | 2.0 | (1.7) | (25.0) | (2.5) | (6.9) | (4.2) | (3.2) | (1.1) | (1.7) | (2.0) |
| Per Share | ||||||||||||||||
| Basic EPS | 1.19 | (0.09) | (0.44) | (1.55) | (3.29) | (0.23) | 0.07 | (1.56) | (1.56) | — | — | — | — | — | — | — |
| Diluted EPS | 1.18 | (0.10) | (0.44) | (1.55) | (3.25) | (0.23) | (0.06) | (1.56) | (1.56) | — | — | — | — | — | — | — |
| Revenue per Share | 2.16 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 48.9 | 47.8 | 46.1 | 43.7 | 42.5 | 38.5 | 27.3 | 19.5 | 16.3 | — | — | — | — | — | — | — |
| Diluted Weighted Avg Shares | 49.3 | 48.6 | 46.1 | 43.7 | 43.1 | 38.5 | — | — | 21.6 | — | — | — | — | 5.0 | 5.0 | — |
| Supplemental | ||||||||||||||||
| EBITDA | — | (14.3) | (2.0) | (10.1) | 0.9 | (30.5) | (4.2) | — | — | — | — | — | — | — | — | — |
| EBIT | 1.7 | (16.6) | (7.1) | (17.2) | (5.9) | (35.2) | (6.2) | (0.2) | 3.7 | (1.1) | (4.9) | (5.0) | (3.1) | (0.3) | (0.9) | (1.2) |
| Effective Tax Rate | -620.5% | — | — | 0.5% | 108.0% | 72.5% | 546.7% | 48.2% | — | — | — | — | — | — | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.